Syndax Pharmaceuticals (SNDX) PT Lowered to $28 at Baird
Tweet
Share
E-mailGet Alerts SNDX Hot Sheet
Price: $19.84 +3.98%
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Baird analyst Joel Beatty lowered the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $28.00 (from $32.00) while maintaining a Outperform rating.
You May Also Be Interested In
- JPMorgan Upgrades Resona Holdings, Inc (8308:JP) (RSNHF) to Overweight
- JX Advanced Metals (5016:JP) PT Lowered to JPY4,800 at JPMorgan
- Verbund AG (VER:AV) (OEZVY) PT Lowered to EUR55.50 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
